⌘K

Home/Filings/4/0000950170-24-040323

4//SEC Filing

Carnes Martha Z. 4

Accession 0000950170-24-040323

CIK 0001958086other

View on SEC.gov Company Profile

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 5:02 PM ET

Size

8.7 KB

Accession

0000950170-24-040323

Insider Transaction Report

Form 4

Period: 2024-04-01

Core Laboratories Inc. /DE/CLB

Carnes Martha Z.

Director

Transactions

Award
Restricted Shares
2024-04-01+9,317→ 9,317 total
Exercise: $0.00→ Common Stock (9,317 underlying)
Exercise/Conversion
Common Stock
2024-04-01+6,419→ 37,011 total
Exercise/Conversion
Restricted Shares
2024-04-01−6,419→ 0 total
Exercise: $0.00→ Common Stock (6,419 underlying)

Footnotes (2)

[F1]The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2025, subject to the terms of issuance.
[F2]The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2024.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Core Laboratories Inc. /DE/

CIK 0001958086

Entity typeother

Related Parties

1

filerCIK 0001678397

Filing Metadata

Form type: 4
Filed: Apr 1, 8:00 PM ET
Accepted: Apr 2, 5:02 PM ET
Size: 8.7 KB

View on SEC.gov